ArticleAmerican journal of translational research2023

Efficacy and safety of glucagon-like peptide-1 receptor agonist combined with sodium-glucose co-transporter-2 inhibitor in the treatment of type 2 diabetes mellitus patients with obesity: a retrospective analysis study.

Jingpu Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.